Centre for Plant Medicine Research makes strides in dev’t of herbal treatment for COVID-19

5


The Centre for Plant Medicine Research (CPMR) at Mampong Akwapem in the Eastern Region, has made progress in the development of herbal medicine for the treatment of COVID-19

Acting Executive Director of the Centre, Dr. Kofi Bobi Barimah, who disclosed this, said his outfit is fast developing the herbal medicine, adding that it will bring great respite to Ghanaians when it is introduced.

He said since the outbreak of the COVID-19 pandemic, the Centre has been working at the laboratory to help find a remedy to the life-threatening virus.

Dr. Barimah dropped the hint in Accra at the launch of an immune boosting food supplement called Thorntina-74 Mixture.

Dr. Barimah said the increase in patient attendance at CPMR to seek treatment is an indication of the strong belief of the efficacy of herbal medicine.

He said this has encouraged the Centre to work on developing a cure for the COVID-19 pandemic.

He revealed that since the outbreak of the pandemic, the facility has witnessed an increase in intake of patients from 80 to 140 per day.

A medical Herbalist of the Kwame Nkrumah University of Science and Technology (KNUST), Dr. Albert Wirekoh-Tawiah, who was part of the team that developed the Thorntina-74 immune booster, said the mixture is prepared with the best herbal products to stand the test of time.

A Scientific Officer of the Ghana Standards Authority, Dr. Kenneth Agbodza, said the Authority has approved the efficacy of the mixture and encouraged all to use it.

A Biomedical and Public Health Researcher, Dr. Richard Eghan, called for collaborative effort between herbal and orthodox Medicine to provide the best form of treatment for patients.

The Managing Director of the Diagnostic Herbal Clinic, originators of the medicine, Yaw Owusu Gyapong, said the immune booster was developed as a response to his own need for an immune booster to promote his general health and help find a solution to the threat posed by  COVID-19 in particular.

Source link